The consequences of TMB and MSI were considered as valid prognostic biomarkers and the reaction indicator of immune treatment among various types of cancers and therefore, the relationship of TMB and MSI with the expression of SRSF3 was conducted to investigate the association between SRSF3 activity and mutation among 33 human pan-cancer types. Here, SRSF3 is linked to cancer.